3Rowley A H, Shulman S T. Kawaseki disease [M] // Behrman R E,Kliegma R M,Arvin A M . Nelson textbook of pediatrics. 16th ed.Philadellphia: W.B. Saunders, 2000 : 725-727.
4Williams RV,Wendy Y,Tcheng L,et al.Anticoagulation in the acute and long-term management of Kawasaki disease.Prog Pediatr Cardiol,2004,19(2):179-188.
5Suzuki A,Miyagawa-Tomita S,Komatsu K,et al.Active remodeling of the coronary arterial lesions in the late phase of Kawasaki disease.Circulation,2000,101 (25):2935-2941.
6Kato H,Sugimura T,Akagi T,et al.Long-term consequences of Kawasaki disease:a 10 to 21-year follow-up study of 594 patients.Circulation,1996,94 (6):1379-1385.
7Dajani AS,Taubert KA,Takahashi M,et al.Guidelines for long-term management of patients with Kawasaki Disease.Report from the Committee on Rheumatic Fever,Endocarditis,and Kawasaki Disease,Concil on Cardiovascular Disease in the Yong,American Heart Association.Circulation,1994,89(2):916-922.
8Newburger JW,Takahashi M,Gerber MA,et al.Diagnosis,treatment,and long-term management of Kawasaki disease:a statement for health professionals from the Committee on Rheumatic Fever,Endocarditis,and Kawasaki Disease,Council on Cardiovascular Disease in the Young,American Heart Association.Circulation,2004,110(17):2747-2771.
9Han RK,Sinclair B,Newman A,et al.Recognition and management of Kawasaki disease.CMAJ,2000,162(6):807-812.
10Brogan PA,Bose A,Burgner D,et al.Kawasaki disease:an evidence based approach to diagnosis,treatment,and proposals for future research.Arch Dis Child,2002,86(4):286-290.
